Emerging infectious diseases pose a significant risk to human health. Severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and Ebola virus epidemics have resulted in significant mortality and economic losses over the last 20 years. As a result, it is critical to prevent the spread of new viruses. Vaccination is the most effective way to prevent this viral disease. In December 2019, Creative Biolabs proposed a virus-like particle (VLP)-based vaccine development service to combat the novel coronavirus (SARS-CoV-2).
For more: https://sars-cov-2.creative-biolabs.com/virus-like-particles-based-vaccine-development-services-for-sars-cov2.htm